GLP-1 Agonists May Help People With Diabetes and Long COVID
From the article
People with type 2 diabetes face increased risk of severe lung conditions. A new study reported that mice treated with GLP-1agonists showed reduced pulmonary fibrosis. Further trials are needed.
Continue reading on ASMYou might also wanna read
GLP-1 Receptor Agonists Linked to Small Risk of Smell and Taste Disturbances in Type 2 Diabetes
A study published in JAMA Otolaryngology-Head & Neck Surgery found that GLP-1 receptor agonists (RAs) used for type 2 diabetes are associate
mdsc.pe·7d agoDiabetes worsens long Covid complications
healthcare-in-europe.com·5d ago
Study: GLP-1 drugs like semaglutide linked to lower amputation risk in diabetes patients with peripheral artery disease
A new study suggests that GLP-1 receptor agonists (like Ozempic and Wegovy) are associated with better outcomes in people with type 2 diabet
medicalnewstoday.com·6d agoGLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
clinicaltrials.gov·8d ago
GLP-1 Receptor Agonists Show Promise for Treating Extragenital Lichen Sclerosus: A Case Report
This case report describes two patients with extragenital lichen sclerosus, a chronic inflammatory skin condition, whose symptoms improved s
doi.org·1mo ago
National Psoriasis Foundation Review Examines GLP-1 Receptor Agonists for Psoriasis with Metabolic Comorbidities
This review from the US National Psoriasis Foundation Medical Board provides an evidence-informed narrative synthesis on GLP-1 receptor agon
doi.org·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.